About: Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease. The company is based in Bala Cynwyd, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.13 (-4.51%)
LRMRNASDAQLarimar Therapeutics Inc
Loading watchlist status…
Larimar Therapeutics Inc share price
LRMR price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
LRMR price performance
-4.29%
5D
11.49%
1M
8.27%
YTD
5.77%
1Y
LRMR price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US-NASDAQ rank
N/ASector Rank
N/ALRMR Market Signals